Fig. 6From: The correlation between HTA recommendations and reimbursement status of orphan drugs in EuropeShare (%) of positive, conditional and negative HTA recommendations for ultra-orphan drugs, oncology orphan drugs as well as non-ultra non-oncology drugs; by country. Source: Author’s own calculations based on data from the websites of the eight HTA agenciesBack to article page